Author Correction: Multiparameter prediction of myeloid neoplasia risk

Muxin Gu^{1

2}, Sruthi Cheloor Kovilakam^{1

2}, William G Dunn^{1

2}, Ludovica Marando^{1

2}, Clea Barcena^{1

2

3}, Irina Mohorianu¹, Alexandra Smith⁴, Siddhartha P Kar^{5

6

7}, Margarete A Fabre^{1

2

8}, Moritz Gerstung⁹, Catherine A Cargo^{10

11}, Luca Malcovati^{12

13}, Pedro M Quiros^{14

15

16}, George S Vassiliou^{17

18

19}

Affiliations

¹ Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
² Department of Haematology, University of Cambridge, Cambridge, UK.
³ Department of Biochemistry and Molecular Biology, Universidad de Oviedo, Oviedo, Spain.
⁴ Epidemiology and Cancer Statistics Group, University of York, York, UK.
⁵ MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
⁶ Section of Translational Epidemiology, Division of Population Health Sciences, Bristol, Medical School, University of Bristol, Bristol, UK.
⁷ Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.
⁸ Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
⁹ Division of Artificial Intelligence in Oncology, DKFZ, Heidelberg, Germany.
¹⁰ Haematological Malignancy Diagnostic Service, St James's Hospital, Leeds, UK.
¹¹ Department of Haematology, Leeds Teaching Hospitals, Leeds, UK.
¹² Department of Molecular Medicine, University of Pavia, Pavia, Italy.
¹³ Department of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
¹⁴ Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. pmquiros@ispasturias.es.
¹⁵ Department of Haematology, University of Cambridge, Cambridge, UK. pmquiros@ispasturias.es.
¹⁶ Instituto de Investigación Sanitaria del Principado de Asturias, ISPA, Oviedo, Spain. pmquiros@ispasturias.es.
¹⁷ Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.
¹⁸ Department of Haematology, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.
¹⁹ Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@cam.ac.uk.

PMID: 37726541
PMCID: PMC10562208
DOI: 10.1038/s41588-023-01532-6

Published Erratum

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Muxin Gu et al. Nat Genet. 2023 Oct.

. 2023 Oct;55(10):1777.

doi: 10.1038/s41588-023-01532-6.

Authors

Affiliations

¹ Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
² Department of Haematology, University of Cambridge, Cambridge, UK.
³ Department of Biochemistry and Molecular Biology, Universidad de Oviedo, Oviedo, Spain.
⁴ Epidemiology and Cancer Statistics Group, University of York, York, UK.
⁵ MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
⁶ Section of Translational Epidemiology, Division of Population Health Sciences, Bristol, Medical School, University of Bristol, Bristol, UK.
⁷ Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.
⁸ Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
⁹ Division of Artificial Intelligence in Oncology, DKFZ, Heidelberg, Germany.
¹⁰ Haematological Malignancy Diagnostic Service, St James's Hospital, Leeds, UK.
¹¹ Department of Haematology, Leeds Teaching Hospitals, Leeds, UK.
¹² Department of Molecular Medicine, University of Pavia, Pavia, Italy.
¹³ Department of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
¹⁴ Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. pmquiros@ispasturias.es.
¹⁵ Department of Haematology, University of Cambridge, Cambridge, UK. pmquiros@ispasturias.es.
¹⁶ Instituto de Investigación Sanitaria del Principado de Asturias, ISPA, Oviedo, Spain. pmquiros@ispasturias.es.
¹⁷ Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.
¹⁸ Department of Haematology, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.
¹⁹ Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@cam.ac.uk.

PMID: 37726541
PMCID: PMC10562208
DOI: 10.1038/s41588-023-01532-6

No abstract available

PubMed Disclaimer

Erratum for

Multiparameter prediction of myeloid neoplasia risk.
Gu M, Kovilakam SC, Dunn WG, Marando L, Barcena C, Mohorianu I, Smith A, Kar SP, Fabre MA, Gerstung M, Cargo CA, Malcovati L, Quiros PM, Vassiliou GS. Gu M, et al. Nat Genet. 2023 Sep;55(9):1523-1530. doi: 10.1038/s41588-023-01472-1. Epub 2023 Aug 24. Nat Genet. 2023. PMID: 37620601 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Affiliations

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources